Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Open-label Study Assessing Efficacy of Bimekizumab in Adult Participants With Pyoderma Gangrenosum Over 24 Weeks

NCT07767864 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07767864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07767864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Open-label Study Assessing Efficacy of Bimekizumab in Adult Participants With Pyoderma Gangrenosum Over 24 Weeks
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma gangrenosum